ArticleFrontiers in immunology2023

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.

Qianhe Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.